Intellectia LogoIntellectia
Product
Resources
Markets
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
Crypto Technical Analysis
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Earnings Trading
Stock Chart Patterns
Daytrading Center

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks
Pricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. TFX
stocks logo

TFX

-
Add to WatchlistAdvanced Chart
$
0.000
0.000(0.000%)
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q2
FY2025Q3
FY2025Q4
771.53M
+2.91%
3.362
-1.68%
790.64M
+3.44%
3.368
-3.49%
843.79M
+6.08%
3.733
-4.03%
Estimates Revision
The market is revising Upward the revenue expectations for Teleflex Incorporated (TFX) for FY2025, with the revenue forecasts being adjusted by 0.47% over the past three months. During the same period, the stock price has changed by -16.41%.
Revenue Estimates for FY2025
Revise Upward
up Image
+0.47%
In Past 3 Month
EPS Estimates for FY2025
Revise Downward
down Image
-5.67%
In Past 3 Month
Stock Price
Go Down
down Image
-16.41%
In Past 3 Month
8 Analyst Rating
up Image0
Wall Street analysts forecast TFX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TFX is 143.40 USD with a low forecast of 135.00 USD and a high forecast of 155.00  USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
7 Hold
1 Sell
Hold
up Image0
Current: 118.310
sliders
Low
135.00
Averages
143.40
High
155.00
up Image0
Current: 118.310
sliders
Low
135.00
Averages
143.40
High
155.00
Truist Securities
Richard Newitter
Hold
Maintains
$149 → $140
2025-04-11
Reason
Truist Securities
Richard Newitter
Price Target
$149 → $140
2025-04-11
Maintains
Hold
Reason
Truist lowered the firm's price target on Teleflex to $140 from $149 and keeps a Hold rating on the shares as part of a broad research note previewing Q1 results in Medical Technology. The group's revenue and earnings are less at risk than it could be for a number of other sub-sectors, which will likely keep investors relatively interested in the space even with some tariff choppiness in the backdrop, though the firm is also bracing for cautious 2025 outlooks as companies and models will likely begin to dial-in some macro uncertainty, the analyst tells investors in a research note.
Citizens Capital Markets
David Turkaly
Hold
Reiterates
n/a
2025-04-02
Reason
Citizens Capital Markets
David Turkaly
Price Target
n/a
2025-04-02
Reiterates
Hold
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-03-12
Reason
Needham
Mike Matson
Price Target
n/a
2025-03-12
Reiterates
Hold
Reason
Morgan Stanley
Patrick Wood
Buy
Maintains
$275 → $191
2025-03-05
Reason
Morgan Stanley
Patrick Wood
Price Target
$275 → $191
2025-03-05
Maintains
Buy
Reason
B of A Securities
Craig Bijou
Hold
to
Sell
Downgrades
$235 → $140
2025-03-04
Reason
B of A Securities
Craig Bijou
Price Target
$235 → $140
2025-03-04
Downgrades
Hold
to
Sell
Reason
Truist Securities
Richard Newitter
Hold
Maintains
$200 → $149
2025-03-03
Reason
Truist Securities
Richard Newitter
Price Target
$200 → $149
2025-03-03
Maintains
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Teleflex Inc (TFX.N) is 9.17, compared to its 5-year average forward P/E of 20.66. For a more detailed relative valuation and DCF analysis to assess Teleflex Inc 's fair value, click here.
    Forward PE
    Forward EV/EBITDA
    Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
20.66
Current PE
9.17
Overvalued PE
27.55
Undervalued PE
13.77

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average EV/EBITDA
16.87
Current EV/EBITDA
8.44
Overvalued EV/EBITDA
21.96
Undervalued EV/EBITDA
11.78

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PS
4.42
Current PS
1.72
Overvalued PS
5.89
Undervalued PS
2.95

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

    Insider
    Hedge Fund
    Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds areSelling! The selling amount has increased 143.92% over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought

TFX News & Events

Events Timeline

(ET)
2025-06-12
06:34:54
Teleflex reports results from study of Arrow Chlorhexidine-Impregnated CVCs
select
2025-05-15 (ET)
2025-05-15
06:51:36
Teleflex's UroLift System shows positive results in two BPH trails
select
2025-05-14 (ET)
2025-05-14
09:49:13
Avantor among 'big callouts' from prime broker filings, says Gordon Haskett
select
Sign Up For More Events
Sign Up For More Events

News

Preview
9.0
06-12Newsfilter
New Prospective Cohort Study Reporting the Efficacy of Arrow™ Chlorhexidine-Impregnated Central Venous Catheters Demonstrates Reduced Infection Rates Among ICU Patients

  • Study Findings: A multinational study involving over 6,670 patients demonstrated a 70.5% reduction in central line-associated bloodstream infections (CLABSI) with the use of Chlorhexidine-impregnated central venous catheters (CVCs) compared to non-impregnated catheters, highlighting their effectiveness against common infection-causing pathogens.

  • Clinical Implications: The research indicates that unprotected CVCs may pose an independent risk factor for CLABSI, reinforcing the importance of using antimicrobial technology in high-risk patients to improve patient outcomes in intensive care settings.

Preview
1.0
06-11Newsfilter
Teleflex Highlights Prostate Health and Quality-of-Life Awareness Through Two Key Public Initiatives During Men's Health Month

  • Prostate Health Awareness Campaign: Timed with National Men's Health Month, Teleflex launched the Prostate Monster ad campaign and the Prostate Education Express mobile center to raise awareness about benign prostatic hyperplasia (BPH) and its impact on men's quality of life, promoting treatment options like the UroLift™ System.

  • Educational Initiatives: The Prostate Education Express will tour major U.S. cities to provide training for physicians and community health talks, emphasizing the importance of prostate health and organ spacing techniques to mitigate side effects during prostate cancer radiation therapy.

Preview
8.0
05-29NASDAQ.COM
Strategy To YieldBoost Teleflex To 22.1% Using Options

  • Dividend Predictability: Dividend amounts for companies like Teleflex Incorporated are often unpredictable and linked to profitability; analyzing historical dividend data can help assess future yields, such as the current 1.1% annualized yield expectation.

  • Options Trading Insights: Recent trading data shows a higher preference for call options among S&P 500 components, with a put:call ratio of 0.58, indicating increased buying interest in calls compared to puts.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Teleflex Inc (TFX) stock price today?

The current price of TFX is 118.31 USD — it has increased 0.5 % in the last trading day.

arrow icon

What is Teleflex Inc (TFX)'s business?

Teleflex Incorporated is a global provider of medical technology products. The Company offers a diverse portfolio of solutions in the therapy areas of anesthesia, emergency medicine, interventional cardiology and radiology, surgical, vascular access, and urology. It primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. It operates in three segments: the Americas, EMEA (Europe, the Middle East and Africa) and Asia (Asia Pacific). Its vascular access product portfolio includes Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous (bone access) systems. Interventional product offerings consist of a portfolio of Arrow branded intra-aortic balloon pumps and catheters, GuideLiner, Turnpike and TrapLiner catheters, the MANTA Vascular Closure device and Arrow OnControl powered bone biopsy system.

arrow icon

What is the price predicton of TFX Stock?

Wall Street analysts forecast TFX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for TFX is 143.40 USD with a low forecast of 135.00 USD and a high forecast of 155.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Teleflex Inc (TFX)'s revenue for the last quarter?

Teleflex Inc revenue for the last quarter amounts to 700.67M USD, decreased -5.04 % YoY.

arrow icon

What is Teleflex Inc (TFX)'s earnings per share (EPS) for the last quarter?

Teleflex Inc. EPS for the last quarter amounts to 2.07 USD, increased 546.87 % YoY.

arrow icon

What changes have occurred in the market's expectations for Teleflex Inc (TFX)'s fundamentals?

The market is revising Upward the revenue expectations for Teleflex Incorporated (TFX) for FY2025, with the revenue forecasts being adjusted by 0.47% over the past three months. During the same period, the stock price has changed by -16.41%.
arrow icon

How many employees does Teleflex Inc (TFX). have?

Teleflex Inc (TFX) has 14100 emplpoyees as of June 23 2025.

arrow icon

What is Teleflex Inc (TFX) market cap?

Today TFX has the market capitalization of 5.23B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerCrypto Technical AnalysisAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings Trading
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySitemap
Start for Free